LMG Wealth Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$493K Sell
17,567
-368
-2% -$9.8K 0.09% 115
2025
Q4
$447K Sell
17,935
-1,060
-6% -$26.7K 0.08% 118
2025
Q3
$484K Buy
18,995
+2,290
+14% +$56.5K 0.09% 113
2025
Q2
$405K Hold
16,705
0.08% 106
2025
Q1
$423K Sell
16,705
-105
-0.6% -$2.75K 0.09% 102
2024
Q4
$446K Buy
16,810
+194
+1% +$5.26K 0.1% 95
2024
Q3
$481K Sell
16,616
-35
-0.2% -$1.02K 0.11% 91
2024
Q2
$466K Sell
16,651
-32,222
-66% -$887K 0.12% 92
2024
Q1
$1.36M Buy
48,873
+12,831
+36% +$356K 0.34% 63
2023
Q4
$1.04M Sell
36,042
-1,921
-5% -$58.1K 0.29% 67
2023
Q3
$1.26M Buy
37,963
+3,990
+12% +$141K 0.38% 60
2023
Q2
$1.25M Buy
33,973
+2,187
+7% +$85.1K 0.38% 55
2023
Q1
$1.3M Buy
31,786
+2,157
+7% +$93.2K 0.42% 57
2022
Q4
$1.37M Buy
+29,629
New +$1.42M 0.45% 51

Other funds holding PFE

LMG Wealth Partners's PFE Position: Q1 2026 in Review

LMG Wealth Partners reduced its Pfizer (PFE) stake by 2.1% in Q1 2026, selling an estimated $9.8K and leaving 17,567 shares worth $493K. The position accounts for 0.09% of the portfolio, ranked #115.

LMG Wealth Partners first reported a position in PFE in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.37M in Q4 2022. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • LMG Wealth Partners held 17,567 shares of Pfizer worth $493K as of Q1 2026.
  • LMG Wealth Partners sold 368 Pfizer shares in Q1 2026, an estimated $9.8K.
  • Pfizer made up 0.09% of LMG Wealth Partners's portfolio in Q1 2026, its #115 holding.
  • LMG Wealth Partners first reported a position in Pfizer in Q4 2022 and has held it in 14 quarters since.
  • LMG Wealth Partners's Pfizer position peaked at $1.37M in Q4 2022.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on LMG Wealth Partners's 13F filing for Q1 2026, filed 17 Apr 2026.